A comparison of statistical methods for prenatal screening for Down syndrome
β Scribed by Christopher J. Williams; Sauchi Stephen Lee; Rachel A. Fisher; Lois H. Dickerman
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 151 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1524-1904
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Maternal serum screening for Down syndrome involves biochemical tests such as alpha-fetoprotein ( FP), human chorionic gonadotrophin (hCG) and unconjugated oestriol (uE 3 ), either alone or in combination, that have variable detection and false-positive rates. Choosing a screening protocol requires
To investigate whether statistical parameters used in Down syndrome screening between 15 and 22 weeks of pregnancy can be used at 14 weeks, we assayed alpha-fetoprotein (AFP), unconjugated oestriol (uE 3 ), total human chorionic gonadotrophin (hCG), free -hCG, free -hCG, and inhibin-A in 16 pregnanc
## Objective: The objective of this study was to conduct an economic evaluation of routine prenatal carrier testing for fragile X syndrome. Methods: This economic analysis was conducted from the societal perspective. A cost-benefit equation was developed based on the premise that the cost of routi